Seeking Alpha盘前汇总MAR、LLY、PTON、TSN多家公司事件

Stock index futures were higher on Monday as investors looked forward to a busy week of corporate earnings and key labor market data.
Here are four stocks to watch on the day:
Marriott International (MAR) shares fell 3.5% in premarket trading after the hotel operator reported mixed second-quarter results and issued weaker-than-expected third-quarter profit guidance. Strong growth in its U.S. and Canada business helped offset only modest gains internationally as the conflict in the Middle East continued to weigh on tourism in the region. Marriott also raised its full-year revenue per available room (RevPAR) outlook, but the improved forecast was overshadowed by its softer profit guidance.
Eli Lilly (LLY) shares rose 1.5% in early trading after the drugmaker said the U.S. Food and Drug Administration granted breakthrough therapy designation to olomorasib for treating adults with advanced pancreatic cancer carrying a KRAS G12C mutation who have received at least one prior systemic therapy. The designation was based on encouraging early results from the Phase 1/2 LOXO-RAS-20001 trial evaluating the treatment in patients with KRAS G12C-mutant advanced solid tumors.
Peloton Interactive (PTON) shares edged up 0.2% in premarket trading even as a federal jury in Delaware ordered the fitness equipment maker to pay Japanese electronics company NEC $20.5 million for infringing a patent covering content-streaming technology. The lawsuit, filed by NEC in 2022, alleged that Peloton's Bike and Tread products violated a U.S. patent related to distributing digital media across multiple devices simultaneously. Peloton had argued that it neither infringed the patent nor that the patent was valid.
Tyson Foods (TSN) shares fell 2.6% in early trading after the meat producer reported mixed fiscal third-quarter results, with revenue missing Wall Street expectations. Sales slipped 0.1% from a year earlier to $13.9 billion, about $200 million below analysts' estimates, although revenue increased 0.6% excluding the impact of a $98 million legal contingency accrual recognized during the quarter.